Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Down 26.6% in September

Viemed Healthcare, Inc. (NASDAQ:VMDGet Free Report) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totalling 205,500 shares, a drop of 26.6% from the September 15th total of 279,900 shares. Based on an average daily trading volume, of 125,800 shares, the short-interest ratio is presently 1.6 days. Currently, 0.6% of the company’s stock are sold short.

Institutional Investors Weigh In On Viemed Healthcare

A number of institutional investors have recently added to or reduced their stakes in VMD. Salem Investment Counselors Inc. boosted its stake in shares of Viemed Healthcare by 118.8% in the 1st quarter. Salem Investment Counselors Inc. now owns 72,007 shares of the company’s stock worth $679,000 after buying an additional 39,090 shares during the last quarter. DORCHESTER WEALTH MANAGEMENT Co increased its position in shares of Viemed Healthcare by 16.0% during the 1st quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 14,480 shares of the company’s stock valued at $137,000 after purchasing an additional 2,000 shares during the last quarter. Essex Investment Management Co. LLC raised its stake in shares of Viemed Healthcare by 1.5% during the 1st quarter. Essex Investment Management Co. LLC now owns 250,109 shares of the company’s stock worth $2,359,000 after purchasing an additional 3,776 shares during the period. Russell Investments Group Ltd. increased its holdings in Viemed Healthcare by 5.3% during the first quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock worth $1,386,000 after buying an additional 7,386 shares during the last quarter. Finally, Pinnacle Wealth Planning Services Inc. purchased a new position in Viemed Healthcare in the first quarter valued at about $135,000. 74.24% of the stock is owned by institutional investors.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $8.77 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.29 and a current ratio of 1.43. The firm’s 50-day simple moving average is $7.48 and its 200 day simple moving average is $7.44. The stock has a market cap of $340.54 million, a price-to-earnings ratio of 36.54 and a beta of 1.47. Viemed Healthcare has a fifty-two week low of $5.90 and a fifty-two week high of $10.44.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.03). The company had revenue of $54.97 million for the quarter. Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Recommended Stories

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.